TNFAIP2 and sarcoma: Except for those cancers [mesothelioma (MESO), SARC (sarcoma) and UVM] whose normal tissue data was unavailable or too few, significant differences in TNFAIP2 expression between tumor and normal tissue were found in 28 types of cancer.